ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer

A.G. van der Zee; N. Colombo; G. Gitsch; N. Reed; F. Amant; D. Cibula; V. Kesic; R. Kimmig; A. Lopes; J. Markowska; C. Marth; A Radolakis; H. Salvesen; D. Vaitkiene; R.H.M. Verheijen; P. Zola

doi:10.1097/IGC.ob013e3182261f15

ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer

Translated title of the contribution: ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer

A.G. van der Zee, N. Colombo, G. Gitsch, N. Reed, F. Amant, D. Cibula, V. Kesic, R. Kimmig, A. Lopes, J. Markowska, C. Marth, A Radolakis, H. Salvesen, D. Vaitkiene, R.H.M. Verheijen, P. Zola

Cancer

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer
Original language	Undefined/Unknown
Pages (from-to)	175
Number of pages	1
Journal	International Journal of Gynaecological Cancer
Volume	22
Issue number	1
DOIs	https://doi.org/10.1097/IGC.ob013e3182261f15
Publication status	Published - 2012

Access to Document

10.1097/IGC.ob013e3182261f15

Cite this

van der Zee, A. G., Colombo, N., Gitsch, G., Reed, N., Amant, F., Cibula, D., Kesic, V., Kimmig, R., Lopes, A., Markowska, J., Marth, C., Radolakis, A., Salvesen, H., Vaitkiene, D., Verheijen, R. H. M., & Zola, P. (2012). ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer. International Journal of Gynaecological Cancer, 22(1), 175. https://doi.org/10.1097/IGC.ob013e3182261f15

@article{e3269ad709264a75ae298e3dcc6bfca0,

title = "ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer",

author = "{van der Zee}, A.G. and N. Colombo and G. Gitsch and N. Reed and F. Amant and D. Cibula and V. Kesic and R. Kimmig and A. Lopes and J. Markowska and C. Marth and A Radolakis and H. Salvesen and D. Vaitkiene and R.H.M. Verheijen and P. Zola",

year = "2012",

doi = "10.1097/IGC.ob013e3182261f15",

language = "Undefined/Unknown",

volume = "22",

pages = "175",

journal = "International Journal of Gynaecological Cancer",

issn = "1048-891X",

publisher = "Lippincott Williams & Wilkins",

number = "1",

}

van der Zee, AG, Colombo, N, Gitsch, G, Reed, N, Amant, F, Cibula, D, Kesic, V, Kimmig, R, Lopes, A, Markowska, J, Marth, C, Radolakis, A, Salvesen, H, Vaitkiene, D, Verheijen, RHM & Zola, P 2012, 'ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer', International Journal of Gynaecological Cancer, vol. 22, no. 1, pp. 175. https://doi.org/10.1097/IGC.ob013e3182261f15

TY - JOUR

T1 - ESGO statement on the role of CA-125 measurement in follow-up of epithelial ovarian cancer

AU - van der Zee, A.G.

AU - Colombo, N.

AU - Gitsch, G.

AU - Reed, N.

AU - Amant, F.

AU - Cibula, D.

AU - Kesic, V.

AU - Kimmig, R.

AU - Lopes, A.

AU - Markowska, J.

AU - Marth, C.

AU - Radolakis, A

AU - Salvesen, H.

AU - Vaitkiene, D.

AU - Verheijen, R.H.M.

AU - Zola, P.

PY - 2012

Y1 - 2012

U2 - 10.1097/IGC.ob013e3182261f15

DO - 10.1097/IGC.ob013e3182261f15

M3 - Article

SN - 1048-891X

VL - 22

SP - 175

JO - International Journal of Gynaecological Cancer

JF - International Journal of Gynaecological Cancer

IS - 1

ER -